Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes

[1]  N. Kawada,et al.  The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease , 2020, International journal of molecular sciences.

[2]  M. Longo,et al.  Nutrition and Genetics in NAFLD: The Perfect Binomium , 2020, International journal of molecular sciences.

[3]  Richard G. Lee,et al.  Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease , 2019, eLife.

[4]  T. Helbich,et al.  Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis , 2019, Nature Communications.

[5]  I. Matsuoka,et al.  Lysophosphatidylinositol‐acyltransferase‐1 is involved in cytosolic Ca2+ oscillations in macrophages , 2019, Genes to cells : devoted to molecular & cellular mechanisms.

[6]  S. Fargion,et al.  miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis , 2018, International journal of molecular sciences.

[7]  M. Longo,et al.  Genetic and Epigenetic Modifiers of Alcoholic Liver Disease , 2018, International journal of molecular sciences.

[8]  H. Reeves,et al.  MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals , 2017, Scientific Reports.

[9]  L. Valenti,et al.  Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. , 2017, Clinical science.

[10]  V. Wong,et al.  The membrane‐bound O‐acyltransferase domain‐containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B , 2017, Hepatology.

[11]  Alka A. Potdar,et al.  EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice , 2017, Nature.

[12]  Jochen Hampe,et al.  The genetics of alcohol dependence and alcohol-related liver disease. , 2017, Journal of hepatology.

[13]  M. Orho-Melander,et al.  The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans. , 2016, Journal of hepatology.

[14]  T. Berg,et al.  MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C , 2016, Nature Communications.

[15]  Luca Valenti,et al.  Genetics of nonalcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.

[16]  Dermot F. Reilly,et al.  The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. , 2016, Gastroenterology.

[17]  G. Gao,et al.  Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism* , 2016, The Journal of Biological Chemistry.

[18]  T. Berg,et al.  MBOAT 7 rs 641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C , 2016 .

[19]  K. Huse,et al.  A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis , 2015, Nature Genetics.

[20]  D. Accili,et al.  The new biology of diabetes , 2015, Diabetologia.

[21]  H. Kiyonari,et al.  Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport , 2015, eLife.

[22]  E. Gratton,et al.  Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion , 2015, eLife.

[23]  J. Borén,et al.  Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease , 2015, Hepatology.

[24]  R. Murphy,et al.  Lysophospholipid acyltransferases and eicosanoid biosynthesis in zebrafish myeloid cells. , 2014, Prostaglandins & other lipid mediators.

[25]  L. N. Valenti,et al.  PNPLA3 I148M polymorphism and progressive liver disease. , 2013, World journal of gastroenterology.

[26]  H. Arai,et al.  Identification of small subunit of serine palmitoyltransferase a as a lysophosphatidylinositol acyltransferase 1‐interacting protein , 2013, Genes to cells : devoted to molecular & cellular mechanisms.

[27]  S. Matsuda,et al.  LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice , 2012, Molecular biology of the cell.

[28]  R. Murphy,et al.  Lysophospholipid Acyltransferases and Arachidonate Recycling in Human Neutrophils* , 2008, Journal of Biological Chemistry.

[29]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[30]  K. Gengyo-Ando,et al.  Member of the membrane‐bound O‐acyltransferase (MBOAT) family encodes a lysophospholipid acyltransferase with broad substrate specificity , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  G. Tell,et al.  Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. , 2008, Trends in molecular medicine.

[32]  K. Gengyo-Ando,et al.  Caenorhabditis elegans mboa-7, a member of the MBOAT family, is required for selective incorporation of polyunsaturated fatty acids into phosphatidylinositol. , 2007, Molecular biology of the cell.

[33]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[34]  K. Feingold,et al.  FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced Obesity , 2006, Molecular and Cellular Biology.

[35]  M. Stoffel,et al.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes , 2004, Nature.

[36]  H. Lodish,et al.  Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.

[37]  S. Mango.  Faculty Opinions recommendation of Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. , 2003 .

[38]  M. Stoffel,et al.  Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Accili,et al.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. , 2001, The Journal of clinical investigation.

[40]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[41]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[42]  S. Kaveri,et al.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. , 1998, The Journal of clinical investigation.

[43]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.